Capital Investment Services of America’s AbbVie ABBV Stock Holding History

Capital Investment Services of America’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Hold	2,103	–	–	0.05%	70
2026 Q1	$457K	Sell	2,103 -42	-2%	-$9.32K	0.05%	70
2025 Q4	$490K	Hold	2,145	–	–	0.05%	70
2025 Q3	$497K	Hold	2,145	–	–	0.04%	69
2025 Q2	$398K	Sell	2,145 -150	-7%	-$27.9K	0.04%	70
2025 Q1	$481K	Hold	2,295	–	–	0.05%	64
2024 Q4	$408K	Hold	2,295	–	–	0.04%	64
2024 Q3	$453K	Buy	2,295 +50	+2%	+$9.33K	0.04%	62
2024 Q2	$385K	Sell	2,245 -250	-10%	-$41.4K	0.04%	63
2024 Q1	$454K	Sell	2,495 -155	-6%	-$26.7K	0.04%	62
2023 Q4	$411K	Hold	2,650	–	–	0.04%	63
2023 Q3	$395K	Sell	2,650 -67	-2%	-$9.84K	0.05%	62
2023 Q2	$366K	Hold	2,717	–	–	0.04%	63
2023 Q1	$433K	Sell	2,717 -136	-5%	-$20.8K	0.05%	60
2022 Q4	$461K	Hold	2,853	–	–	0.06%	60
2022 Q3	$383K	Hold	2,853	–	–	0.05%	62
2022 Q2	$437K	Sell	2,853 -600	-17%	-$91.7K	0.06%	61
2022 Q1	$468K	Hold	3,453	–	–	0.04%	63
2021 Q4	$468K	Sell	3,453 -50	-1%	-$5.91K	0.04%	63
2021 Q3	$378K	Sell	3,503 -1,150	-25%	-$131K	0.04%	63
2021 Q2	$524K	Hold	4,653	–	–	0.05%	61
2021 Q1	$504K	Buy	4,653 +582	+14%	+$62.3K	0.05%	60
2020 Q4	$436K	Buy	4,071 +1,168	+40%	+$112K	0.05%	59
2020 Q3	$254K	Hold	2,903	–	–	0.03%	63
2020 Q2	$285K	Hold	2,903	–	–	0.04%	60
2020 Q1	$221K	Hold	2,903	–	–	0.04%	62
2019 Q4	$257K	Hold	2,903	–	–	0.03%	64
2019 Q3	$220K	Hold	2,903	–	–	0.03%	66
2019 Q2	$211K	Hold	2,903	–	–	0.03%	66
2019 Q1	$234K	Hold	2,903	–	–	0.04%	62
2018 Q4	$268K	Hold	2,903	–	–	0.05%	63
2018 Q3	$275K	Sell	2,903 -133	-4%	-$12.6K	0.04%	64
2018 Q2	$281K	Hold	3,036	–	–	0.04%	63
2018 Q1	$287K	Sell	3,036 -500	-14%	-$54.9K	0.04%	64
2017 Q4	$342K	Hold	3,536	–	–	0.05%	64
2017 Q3	$314K	Hold	3,536	–	–	0.05%	64
2017 Q2	$256K	Hold	3,536	–	–	0.04%	64
2017 Q1	$230K	Hold	3,536	–	–	0.04%	67
2016 Q4	$221K	Hold	3,536	–	–	0.04%	68
2016 Q3	$223K	Hold	3,536	–	–	0.04%	65
2016 Q2	$219K	Hold	3,536	–	–	0.04%	62
2016 Q1	$202K	Sell	3,536 -800	-18%	-$44.6K	0.04%	65
2015 Q4	$257K	Sell	4,336 -50	-1%	-$2.88K	0.05%	64
2015 Q3	$239K	Hold	4,386	–	–	0.06%	55
2015 Q2	$295K	Hold	4,386	–	–	0.07%	53
2015 Q1	$257K	Sell	4,386 -117	-3%	-$7.07K	0.06%	51
2014 Q4	$295K	Buy	4,503 +117	+3%	+$7.38K	0.07%	54
2014 Q3	$253K	Hold	4,386	–	–	0.06%	51
2014 Q2	$248K	Hold	4,386	–	–	0.06%	49
2014 Q1	$225K	Hold	4,386	–	–	0.06%	52
2013 Q4	$232K	Sell	4,386 -500	-10%	-$24.6K	0.06%	52
2013 Q3	$219K	Hold	4,886	–	–	0.06%	54
2013 Q2	$202K	Buy	+4,886	New	+$214K	0.06%	56

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Capital Investment Services of America's ABBV Position: Q2 2026 in Review

Capital Investment Services of America held its AbbVie (ABBV) position steady in Q2 2026 at 2,103 shares worth $529K. The position accounts for 0.05% of the portfolio, ranked #70.

Capital Investment Services of America first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 3,435 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Capital Investment Services of America held 2,103 shares of AbbVie worth $529K as of Q2 2026.
Capital Investment Services of America left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.05% of Capital Investment Services of America's portfolio in Q2 2026, its #70 holding.
Capital Investment Services of America first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
3,435 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capital Investment Services of America's 13F filing for Q2 2026, filed 22 Jul 2026.